NCT03352791

Brief Summary

Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare and hospice, most clinicians and agencies are ill prepared to care for this population and therefore have difficulty assisting patients and caregivers in maintaining quality of life leading to adverse patient outcomes, increased caregiver stress and burnout, and healthcare utilization. This study will utilize a cluster randomized controlled design with 6 care teams at a single study site to examine the ability of a multi-component evidence-based practice hospice care quality improvement program for registered nurses, social workers and chaplains to improve the quality of life and reduce healthcare utilization for persons with dementia and their informal caregiver.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 24, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2018

Completed
Last Updated

December 4, 2019

Status Verified

December 1, 2019

Enrollment Period

2 months

First QC Date

November 21, 2017

Last Update Submit

December 2, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Reduction in pain (PAINAD)

    pain assessment tool for use in persons with moderate to severe dementia who cannot provide reliable report, and will be used if the QDRS\>12

    Day 0 and Day 30

  • Reduction in Behavioral and Psychological Symptoms of Dementia (BPSD) using Neuropsychiatric Inventory Questionnaire (NPI-Q):

    13-item tool that measures caregiver perception of BPSD presence and severity in PWD

    Day 0 and Day 30

Study Arms (2)

DSM-H Hospice Edition

ACTIVE COMPARATOR

training, assigning of champions to serve as mentors and performance improvement leads, and workflow changes including caregiver education pamphlets, interdisciplinary care plans, treatment algorithms, and assessment instruments.

Behavioral: DSM-H Hospice Edition performance improvement program

Control Arm

ACTIVE COMPARATOR

Usual Care

Behavioral: Usual Care

Interventions

Patients in the performance improvement group will receive care from a care team who has received the DSM-H Hospice Edition performance improvement program

DSM-H Hospice Edition
Usual CareBEHAVIORAL

control will receive usual care from a care team who has not received the performance improvement program.

Control Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PWD over the age of 65
  • Admitted to MJHS hospice agency
  • The patient and family caregiver speak English and/or Spanish.
  • The informal caregiver is ≥18 years of age and spends at least 8 hours per week with the patient.
  • Patients who score ≥6 on the Quick Dementia Rating Scale (at least mild impairment).

You may not qualify if:

  • Patients with a separate Axis 1 diagnosis other than forms of dementia, depression or anxiety.
  • PWD residing in assisted living facilities, nursing homes or board and care homes
  • PWD solely receiving infusion or home health aide services.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Abraham Brody, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2017

First Posted

November 24, 2017

Study Start

August 1, 2018

Primary Completion

October 5, 2018

Study Completion

October 5, 2018

Last Updated

December 4, 2019

Record last verified: 2019-12

Locations